IDEXX is trading 4.67% up at $539.48 before the October 7, 2026 session; no clear company-specific catalyst has been identified.

  • An October 7 article discusses the CoVetAI acquisition, completed September 16, but does not establish a new overnight event or explain the gain.
  • The next quarterly results are scheduled for November 2.
  • Major U.S. indices are mixed and barely changed in the supplied market context, which does not establish a broad-market explanation.